Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ).
Charmacy Pharmaceutical Co., Ltd. has announced a final cash dividend of RMB 0.45 per share for the financial year ending December 31, 2024. The dividend is set to be approved by shareholders on May 22, 2025, with payment scheduled for July 11, 2025. This announcement reflects the company’s financial performance and commitment to returning value to its shareholders, potentially impacting its market positioning and stakeholder confidence.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the distribution and sale of pharmaceutical products. The company is involved in providing a range of healthcare solutions and services.
YTD Price Performance: -20.61%
Average Trading Volume: 4,888
Technical Sentiment Signal: Buy
Current Market Cap: HK$840.2M
For a thorough assessment of 2289 stock, go to TipRanks’ Stock Analysis page.